Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/35022
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorCERVANTES, C.
dc.contributor.authorHUGHES, T.
dc.contributor.authorETIENNE, G.
dc.contributor.authorSOUZA, C. A. De
dc.contributor.authorLLACER, P. E. Dorlhiac
dc.contributor.authorSCHWARER, A.
dc.contributor.authorLEBER, B.
dc.contributor.authorLIPTON, J.
dc.contributor.authorSPECTOR, N.
dc.contributor.authorREYNOLDS, J.
dc.contributor.authorCOLLINS, L.
dc.contributor.authorSZCZUDLO, T.
dc.contributor.authorREA, D.
dc.date.accessioned2020-02-03T17:30:41Z-
dc.date.available2020-02-03T17:30:41Z-
dc.date.issued2012
dc.identifier.citationHAEMATOLOGICA, v.97, suppl.1, p.239-239, 2012
dc.identifier.issn0390-6078
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/35022-
dc.language.isoeng
dc.publisherFERRATA STORTI FOUNDATIONeng
dc.relation.ispartofHaematologica
dc.rightsopenAccesseng
dc.titleNILOTINIB INDUCES DEEPER MOLECULAR RESPONSES VS CONTINUED IMATINIB IN PATIENTS WITH PH plus CHRONIC MYELOID LEUKEMIA (CML) WITH DETECTABLE DISEASE AFTER=2 YEARS ON IMATINIB: ENESTCMR 12-MONTH RESULTSeng
dc.typeconferenceObjecteng
dc.rights.holderCopyright FERRATA STORTI FOUNDATIONeng
dc.subject.wosHematologyeng
dc.type.categorymeeting abstracteng
dc.type.versionpublishedVersioneng
hcfmusp.author.externalCERVANTES, C.:Univ Barcelona, Barcelona, Spain
hcfmusp.author.externalHUGHES, T.:Royal Adelaide Hosp, Adelaide, SA, Australia
hcfmusp.author.externalETIENNE, G.:Inst Bergonie, Bordeaux, France
hcfmusp.author.externalSOUZA, C. A. De:Univ Campinas SP, Campinas, SP, Brazil
hcfmusp.author.externalSCHWARER, A.:Alfred Hosp, Melbourne, Vic, Australia
hcfmusp.author.externalLEBER, B.:Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada
hcfmusp.author.externalLIPTON, J.:Princess Margaret Hosp, Toronto, ON, Canada
hcfmusp.author.externalSPECTOR, N.:Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil
hcfmusp.author.externalREYNOLDS, J.:Novartis Pharma AG, Basel, Switzerland
hcfmusp.author.externalCOLLINS, L.:Novartis Pharmaceut, E Hanover, NJ USA
hcfmusp.author.externalSZCZUDLO, T.:Novartis Pharmaceut, E Hanover, NJ USA
hcfmusp.author.externalREA, D.:Hop St Louis, Serv Malad Sang, Paris, France
hcfmusp.description.beginpage239
hcfmusp.description.endpage239
hcfmusp.description.issuesuppl 1
hcfmusp.description.volume97
hcfmusp.origemWOS
hcfmusp.origem.idWOS:000496830402108
hcfmusp.publisher.cityPAVIAeng
hcfmusp.publisher.countryITALYeng
dc.description.indexMEDLINEeng
Appears in Collections:

Comunicações em Eventos - HC/ICHC
Instituto Central - HC/ICHC


Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.